Beck Bode LLC’s Apellis Pharmaceuticals APLS Stock Holding History

Beck Bode LLC’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-312,841	Closed	-$12.6M	–	113
2026 Q1	$12.6M	Buy	+312,841	New	+$6.74M	2.13%	26

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Beck Bode LLC's APLS Position: Q2 2026 in Review

Beck Bode LLC sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 312,841 shares — an estimated $12.6M sold.

Beck Bode LLC first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $12.6M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Beck Bode LLC reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Beck Bode LLC sold 312,841 Apellis Pharmaceuticals shares in Q2 2026, an estimated $12.6M.
Beck Bode LLC first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Beck Bode LLC's Apellis Pharmaceuticals position peaked at $12.6M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.